Leonardo Gatticchi

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondria.

Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondria.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: April 23, 2025

Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.

Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.

Journal: The Journal of biological chemistry

Published: April 14, 2025

Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities.

Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities.

Journal: Biomolecules

Published: November 15, 2023

Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.

Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.

Journal: Biochemical and biophysical research communications

Published: December 30, 2022

Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis.

Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis.

Journal: American journal of respiratory cell and molecular biology

Published: October 17, 2022

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.

Journal: Molecular neurodegeneration

Published: August 26, 2022

CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1.

CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1.

Journal: Biochimie

Published: December 22, 2021

Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach.

Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 28, 2021

Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factors.

Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factors.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 06, 2021

The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells.

The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells.

Journal: Heliyon

Published: August 25, 2020

Tm7sf2 Disruption Alters Radial Gene Positioning in Mouse Liver Leading to Metabolic Defects and Diabetes Characteristics.

Tm7sf2 Disruption Alters Radial Gene Positioning in Mouse Liver Leading to Metabolic Defects and Diabetes Characteristics.

Journal: Frontiers in cell and developmental biology

Published: August 07, 2020

Recessive multiple epiphyseal dysplasia and Stargardt disease in two sisters.

Recessive multiple epiphyseal dysplasia and Stargardt disease in two sisters.

Journal: Molecular genetics & genomic medicine

Published: May 18, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026